Posted inStock Dow futures slip 214 points amid Fed jitters: 5 things to know before Wall Street opens Dow futures were under pressure on Friday, falling about 214 points, roughly 0.5% as investors… November 14, 2025 Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock How Caterpillar is emerging as an AI giant: Wells Fargo Caterpillar shares may still have room to climb, according to Wells Fargo, which initiated coverage… November 14, 2025 Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Goldman Sachs says this AI name is a better pick than Palantir stock for 2026 Palantir Technologies Inc (NASDAQ: PLTR) has pulled back in recent days amidst a broader sell-off… November 14, 2025 Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock MSTR stock price analysis as mNAV drops below 1 The MSTR stock price has collapsed this year, moving from the year-to-date high of $456… November 14, 2025 Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock The next wave of AI-driven cost cuts: Vista and Meta send clear signals this week The private equity and big tech playbooks are converging on a singular strategy: replace expensive… November 14, 2025 Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Merck to buy Cidara Therapeutics for $9.2 billion as Keytruda patent cliff approaches Merck & Co. has agreed to acquire biotechnology firm Cidara Therapeutics in a $9.2 billion… November 14, 2025
Posted inStock Earnings season preview: what to expect in Q3 earnings The earnings season will kick off this week and will be the main catalyst for… October 12, 2025
Posted inStock To catalysts to move the S&P 500 Index and its ETFs like SPY and VOO this week The S&P 500 Index and its ETFs, like SPY and VOO suffered a harsh reversal… October 12, 2025
Posted inPolitics Hamas co-founder snaps after being questioned on Oct 7 aftermath: ‘Go to hell’ A prominent Hamas leader lost his temper and stormed off from a live interview after… October 12, 2025
Posted inPolitics Biden undergoes radiation therapy for cancer, spokesperson says Former President Joe Biden is entering a new phase of treatment for the prostate cancer… October 12, 2025
Posted inPolitics Albanian judge killed in courtroom shooting amid growing anger over justice system reforms On Oct. 6, Albanian Appeals Court Judge Astrit Kalaja was shot inside the Tirana courtroom… October 12, 2025
Posted inPolitics Hamas co-founder snaps after being questioned on Oct. 7 aftermath: ‘Go to hell’ A prominent Hamas leader lost his temper and stormed off from a live interview after… October 12, 2025
Posted inPolitics Trump directs Hegseth to pay troops during ongoing government shutdown standoff as he rails against Schumer President Donald Trump railed against Democrats over the ongoing government shutdown Saturday, and said he… October 12, 2025
Posted inPolitics I was kidnapped by Boko Haram, and survived. No thanks to the West’s silence Two years ago, I was kidnapped by Boko Haram. They held me captive, and every… October 12, 2025
Posted inPolitics Trump announces shakeup at top of WH personnel office White House Deputy Chief of Staff Dan Scavino is poised to play an even larger… October 12, 2025
Posted inStock PepsiCo stock: major reason its beverage unit has trailed Coca-Cola for years Activist investor Elliott Management says PepsiCo’s (NASDAQ: PEP) North American beverage unit has underperformed Coca-Cola… October 11, 2025